USA FINANCIAL FORMULAS’s AbbVie ABBV Stock Holding History

USA FINANCIAL FORMULAS’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.8K	Buy	+158	New	+$34K	0.01%	307

Other funds holding ABBV

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

USA FINANCIAL FORMULAS's ABBV Position: Q2 2026 in Review

USA FINANCIAL FORMULAS opened a new position in AbbVie (ABBV) in Q2 2026: 158 shares worth $39.8K. The stake represents 0.01% of the portfolio and ranks #307 among its holdings.

2,450 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

USA FINANCIAL FORMULAS held 158 shares of AbbVie worth $39.8K as of Q2 2026.
AbbVie was a new USA FINANCIAL FORMULAS position in Q2 2026.
AbbVie made up 0.01% of USA FINANCIAL FORMULAS's portfolio in Q2 2026, its #307 holding.
2,450 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on USA FINANCIAL FORMULAS's 13F filing for Q2 2026, filed 4 Aug 2026.